p53激活后的转录程序。 - Suppr

Suppr

超能文献

The transcriptional program following p53 activation.

作者信息

Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman W H, Tom E, Mack D H, Levine A J

机构信息

Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544, USA.

出版信息

Cold Spring Harb Symp Quant Biol. 2000;65:475-82. doi: 10.1101/sqb.2000.65.475.

DOI:10.1101/sqb.2000.65.475

PMID:12760064

Abstract

摘要

相似文献

The transcriptional program following p53 activation.

Cold Spring Harb Symp Quant Biol. 2000;65:475-82. doi: 10.1101/sqb.2000.65.475.

Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53.

Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15632-7. doi: 10.1073/pnas.242597299. Epub 2002 Nov 15.

Expression of prostate specific antigen (PSA) is negatively regulated by p53.

Oncogene. 2002 Jan 3;21(1):153-7. doi: 10.1038/sj.onc.1205001.

DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1.

Oncogene. 2001 Jun 7;20(26):3449-55. doi: 10.1038/sj.onc.1204446.

Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene.

Oncogene. 1993 Dec;8(12):3411-6.

RNA polymerase III transcription can be derepressed by oncogenes or mutations that compromise p53 function in tumours and Li-Fraumeni syndrome.

Oncogene. 2002 May 2;21(19):2961-70. doi: 10.1038/sj.onc.1205372.

Isolation and characterization of sixteen novel p53 response genes.

Oncogene. 2000 Aug 17;19(35):3978-87. doi: 10.1038/sj.onc.1203747.

Cancer Lett. 2004 Feb 10;204(1):41-51. doi: 10.1016/j.canlet.2003.07.005.

Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.

Oncol Res. 1996;8(7-8):317-23.

Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.

Mol Med. 1995 Jan;1(2):142-52.

引用本文的文献

MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

J Hematol Oncol. 2021 Aug 9;14(1):121. doi: 10.1186/s13045-021-01111-4.

The Role of JMY in p53 Regulation.

Cancers (Basel). 2018 May 31;10(6):173. doi: 10.3390/cancers10060173.

Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers.

Int J Mol Sci. 2017 May 3;18(5):961. doi: 10.3390/ijms18050961.

Replication licensing and the DNA damage checkpoint.

Front Biosci (Landmark Ed). 2009 Jun 1;14(13):5013-30. doi: 10.2741/3584.

Sequence analysis of p53 response-elements suggests multiple binding modes of the p53 tetramer to DNA targets.

Nucleic Acids Res. 2007;35(9):2986-3001. doi: 10.1093/nar/gkm192. Epub 2007 Apr 16.

Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor.

Genes Dev. 2006 Sep 1;20(17):2373-82. doi: 10.1101/gad.1456306.

Comparison of the protein-protein interfaces in the p53-DNA crystal structures: towards elucidation of the biological interface.

Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):3988-93. doi: 10.1073/pnas.0500215102. Epub 2005 Feb 28.

Modulation of mammalian life span by the short isoform of p53.

Genes Dev. 2004 Feb 1;18(3):306-19. doi: 10.1101/gad.1162404.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验